Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunoglobulin Isotype Profiling of Anti-Factor H Autoantibodies in Complement-Mediated Diseases.

International journal of laboratory hematology·2026
Same author

Immune Deposits, Complement Activation, and <italic>APOL1</italic> Risk Variants in Focal Segmental Glomerulosclerosis.

American journal of nephrology·2026
Same author

Comparison of Three ELISA Assays for the Detection and Quantification of Autoantibodies Against Complement Factor H.

International journal of laboratory hematology·2025
Same author

Haemostasis alterations in immune thrombocytopenia and their clinical significance.

Research and practice in thrombosis and haemostasis·2025
Same author

Concomitant Acquired Hemophilia A and Acquired Von Willebrand Syndrome from Distinctive Autoantibodies: Case Report.

Hematology reports·2025
Same author

The impact of the COVID-19 pandemic on incidence and clinical presentation of thrombotic microangiopathies: data from a laboratory centralizing ADAMTS-13 testing in Quebec.

Orphanet journal of rare diseases·2025

Related Experiment Video

Updated: Jun 29, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
08:30

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation

Published on: August 14, 2017

Thrombospondin-1 in von Willebrand factor function.

Arnaud Bonnefoy1, Marc F Hoylaerts

  • 1INSERM U743, Centre de Recherche du Centre Hospitalier de l'Université de Montréal-Saint-Luc, Montréal QCH2X1P1, Canada.

Current Drug Targets
|October 16, 2008
PubMed
Summary

Thrombospondin-1 (TSP1) stabilizes platelet aggregates and influences von Willebrand factor (VWF) processing by competing with ADAMTS13. This interaction is crucial for hemostasis in inflammatory and thrombotic conditions.

More Related Videos

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions
10:24

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions

Published on: June 11, 2015

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
11:42

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Published on: July 10, 2017

Related Experiment Videos

Last Updated: Jun 29, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
08:30

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation

Published on: August 14, 2017

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions
10:24

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions

Published on: June 11, 2015

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
11:42

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Published on: July 10, 2017

Area of Science:

  • Hematology
  • Molecular Biology
  • Biochemistry

Background:

  • Thrombospondin-1 (TSP1) is a platelet alpha-granule protein that stabilizes aggregates, particularly under shear stress.
  • von Willebrand factor (VWF) is stored as ultralarge multimers in platelets and endothelial cells, and is processed by ADAMTS13.
  • ADAMTS13 shares sequence homology with TSP1 repeats, suggesting a functional relationship.

Purpose of the Study:

  • To investigate the interplay between TSP1 and VWF in platelet function and hemostasis.
  • To elucidate TSP1's role in VWF multimer processing mediated by ADAMTS13.
  • To understand TSP1-VWF interactions in the context of vascular inflammation and thrombosis.

Main Methods:

  • Murine Tsp1(-/-) platelet aggregation and aggregate stabilization assays.
  • Analysis of VWF multimer processing in the presence of TSP1 and ADAMTS13.
  • Investigation of platelet recruitment to VWF and TSP1 under flow conditions.

Main Results:

  • TSP1 is not essential for platelet aggregation but reinforces aggregate stabilization.
  • Platelet-released TSP1 competes with ADAMTS13, modulating VWF multimer processing.
  • TSP1 and VWF interact with the platelet GPIb/V/IX complex, influencing platelet recruitment, with TSP1 showing weak competition with VWF adhesion.

Conclusions:

  • TSP1 plays a significant role in ADAMTS13-mediated VWF multimer processing, especially in pro-inflammatory and thrombotic states.
  • TSP1 and VWF exhibit partially overlapping hemostatic functions, with TSP1's primary contribution being the regulation of VWF processing.
  • Understanding TSP1-VWF interactions is key to comprehending hemostasis in pathological conditions.